Literature DB >> 3049278

Speaking fundamental frequency characteristics of normal Swedish subjects obtained by glottal frequency analysis.

M I Pegoraro Krook.   

Abstract

Mesh：

Year:  1988        PMID： 3049278     DOI： 10.1159/000265888

Source DB:  PubMed          Journal:  Folia Phoniatr (Basel)        ISSN： 0015-5705


× No keyword cloud information.
  7 in total

1.  Acoustical recognition of laryngeal pathology: a comparison of two strategies based on sets of features.

Authors:  E Perrin; C Berger-Vachon; L Collet
Journal:  Med Biol Eng Comput       Date:  1999-09       Impact factor: 2.602

2.  Acoustical recognition of laryngeal pathology using the fundamental frequency and the first three formants of vowels.

Authors:  E Perrin; C Berger-Vachon; I Kauffmann; L Collet
Journal:  Med Biol Eng Comput       Date:  1997-07       Impact factor: 2.602

3.  Acoustic analysis of surgeons' voices to assess change in the stress response during surgical in situ simulation.

Authors:  Andrew Hall; Kosuke Kawai; Kelsey Graber; Grant Spencer; Christopher Roussin; Peter Weinstock; Mark S Volk
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2021-04-13

4.  Dysarthria in bilateral thalamic infarction. A case study.

Authors:  H Ackermann; W Ziegler; D Petersen
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

5.  [Effects of different tasks on determination of the speaking fundamental frequency].

Authors:  B Barsties
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

6.  The Relation Between Vocal Pitch and Vocal Emotion Recognition Abilities in People with Autism Spectrum Disorder and Typical Development.

Authors:  Stefanie Schelinski; Katharina von Kriegstein
Journal:  J Autism Dev Disord       Date:  2019-01

7.  Impact of early postnatal androgen exposure on voice development.

Authors:  Leila Grisa; Maria L Leonel; Maria I R Gonçalves; Francisco Pletsch; Elis R Sade; Gislaine Custódio; Ivete P S Zagonel; Carlos A Longui; Bonald C Figueiredo
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.